← Evidence map

ArticleTherapeutic advances in neurological disorders2021

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients.

Kimberley Allen-Philbey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35173808